About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

miRNA Biomarkers in Multiple Sclerosis

NCT04772495·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University of Gaziantep

Age

25–any

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

The age of 25 years and above
at least one Central Nervous System (CNS) demyelination event

You may not be if

with genetic diseases, hypertension, head trauma, neuropsychiatric disease, diabetes mellitus, hypertension, cardiac failure, hepatic failure, renal failure, Thalassemia, Sickle cell disease, iron deficiency, and B12 deficiency

The record

StatusCompleted

PhaseNo phase

Taking part69

StartedMay 2015

UpdatedFeb 26, 2021

Conditions

Multiple Sclerosis miRNA Epigenetic Biomarker

Clareo Health | miRNA Biomarkers in Multiple Sclerosis